MAPK8 and arthritic joint disease: Previous studies demonstrated that SP600125 and IQ-1S, which are both JNK inhibitors, could reduce the development and pathogenesis of arthritis when evaluated in animal models (Han et al., 2001; Han et al., 2012; Schepetkin et al., 2015).